Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,892Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Avodart

PharmaCompass

01

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

02

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

03

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

Brand Name : Avodart

arrow
Immuno-Oncology 360
Not Confirmed

Dutasteride

Main Therapeutic Indication : Urology

Currency : USD

2022 Revenue in Millions : 407

2021 Revenue in Millions : 449

Growth (%) : -9

blank

04

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

Brand Name : Avodart

arrow
Immuno-Oncology 360
Not Confirmed

Dutasteride

Main Therapeutic Indication : Urology

Currency : USD

2023 Revenue in Millions : 372

2022 Revenue in Millions : 407

Growth (%) : 5

blank

05

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

06

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

07

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

08

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

09

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed

Brand Name : Avodart

arrow
Immuno-Oncology 360
Not Confirmed

Dutasteride

Main Therapeutic Indication : Renal Disorders

Currency : USD

2018 Revenue in Millions : 761

2017 Revenue in Millions : 815

Growth (%) : -7%

blank

10

Brand Name : Avodart

Dutasteride

arrow
Immuno-Oncology 360
Not Confirmed